Infection is a common cause of death in acute leukaemia. Its (Martinez-G et al., 1973 , Steigbigel et al., 1974 Mackie et al., 1979) .
The acute-phase protein response to infection is rapid enough to be of potential value as a screening test, since the level of C-reactive protein (C-RP) may rise some 6 hours after an acute stimulus (Kushner and Broder, 1972; Yen-Watson and Kushner, 1974) . If this early rise occurs reliably in response to infection, then serial measurement would be of potentially greater clinical value than bacteriological culture for early diagnosis. The present study was therefore designed to assess the value of three acute-phase proteins (C-RP, alantitrypsin, and orosomucoid) as screening tests for infection in leukaemia.
Patients and methods
Thirty-eight patients with leukaemia (20 acute myeloblastic, five chronic granulocytic, six acute lymphoblastic, and seven chronic lymphocytic) were studied. Blood was taken at outpatient Received for publication 14 June 1979 attendances when the patients were also examined for clinical signs of infection and samples were taken for bacteriological culture when relevant. Blood samples from inpatients were taken at least three times a week with additional specimens during pyrexia. Inpatients were examined for infection at least once daily, and samples for culture were taken whenever infection was suspected; in addition, swabs from the nose, throat, axillae, and perineum were cultured at least weekly.
Patients with a clinical diagnosis of infection were divided into two groups: patients from whom pathogens could not be isolated on microbiological culture, and patients with microbiological confirmation of infection. Patients with neither clinical nor microbiological evidence of infection were grouped into those in leukaemic remission and those in relapse.
Blood samples were centrifuged, and the serum was stored at 4°in sterile containers to which molar sodium azide solution (0-05 ml per 5 ml serum) had been added. Levels of C-RP, cxil-antitrypsin, and orosomucoid were subsequently measured by radial immunodiffusion (Mancini et al., 1965) using commercial antisera (Seward Immunostics) for aol-antitrypsin and orosomucoid and an antiserum raised to purified human C-RP. The latter antigen was isolated from human ascitic fluid, by a modification of the method of Hokama and Riley (1963) Levels of atl-antitrypsin at the beginning of the 34 episodes of infection, whether confirmed microbiologically or not, were significantly higher (P < 0-001, Kolmogorov-Smirnov two-sample test (Siegel, 1956) ) than the levels for all uninfected patients whether in leukaemic remission or relapse (115 observations) (Fig. 1) . There was considerable overlap, however, some levels at the beginning of infection falling within the normal range.
For orosomucoid (Fig. 2) , levels at the beginning of infection were again significantly higher (P < 0-001) than in uninfected patients. For C-RP, however, there was minimal overlap between infected and uninfected patients (Fig. 3) . The latter, whether in leukaemic remission or relapse, had C-RP levels below 100 mg/l, with only four exceptions out of 290 measurements; the maximum C-RP level was 110 mg/l. C-RP levels showed no correlation with the degree of peripheral blood leucocytosis (in chronic leukaemia) or blast cell count (in acute leukaemia). C-RP was measured more frequently than the other two acute-phase proteins to confirm lack of overlap between infected and uninfected patients. Conversely, in infection, levels of 100 mg/l or above were obtained in the first blood specimen taken, with only two exceptions out of 34 infective episodes. In both of these cases C-RP levels exceeded 100 mg/I on the next day. Resolution of infection was accompanied by a fall in the C-RP level over three to four days.
Discussion
This study suggests that a C-RP level above 100 mg/l may be a useful early indicator of infection in leukaemic patients. There is an interval of about 6 hours between a stimulus, such as the onset of acute inflammation or infection, and elevation of C-RP Kushner, 1974) . Nevertheless, in our study, the first serum sample taken in each infective episode had a C-RP level that was nearly always elevated above 100 mg/l. Presumably there is a latent period of several hours between the onset of infection and the development of clinical signs, C-RP levels increasing significantly during this interval. The exact time sequence for the development of pyrexia, clinical evidence of infection, and elevation of C-RP above 100 mg/l requires to be determined by prospective study. 
alone (17) uninfected patients were receiving cytotoxic drugs, antibiotics, or blood products, which were followed in some cases by pyrexia and rigors. Nevertheless, with four exceptions out of 290 measurements, these patients had C-RP levels below 100 mg/l. The acute-phase response to infection, however, was quantitatively much greater and also occurred in those infected patients whose inflammatory response was clinically masked by severe neutropenia.
Measurement of xl-antitrypsin and orosomucoid, which are not elevated until 24-48 hours after an acute stimulus (Crockson et al., 1966; Werner, 1969) , gave no additional information. C-RP was measured by radial immunodiffusion with a between-batch variability of 10%; a level of 
